Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Jun;37(6):616–619. doi: 10.1136/jcp.37.6.616

Epidermal Langerhans' cells in Behçet's disease.

S Kohn, S Haim, A Gilhar, R Friedman-Birnbaum, I Nir
PMCID: PMC498833  PMID: 6725610

Abstract

Langerhans' cells were studied in the epidermis of two patients with active Behçet's disease and compared with those in two normal controls. Ultrastructural morphology and the percentage of Langerhans' cells found were similar in patients' (1.88%) and the control epidermis (1.79%). The density of Langerhans' cells in adjacent sites of the same epidermis was not homogeneous, being in the range of 0.8-2.8% in Behçet's disease and 0.6-4% in the controls. In the controls, Langerhans' cells were distributed unevenly. Some were located near the basal layer of the epidermis while the rest were in the mid and upper layers. In Behçet's disease most Langerhans' cells were in the mid-epidermis, but some were immediately beneath the stratum granulosum. In the Behçet's disease epidermis the area occupied by Langerhans' cells was increased by about 25% and the number of granules found increased by about 44%. It is suggested that in Behçet's disease the Langerhans' cells are in a more active state.

Full text

PDF
616

Images in this article

617Image
on p.617
618Image
on p.618

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baer R. L. Introductory remarks to the session on Langerhans cells. J Invest Dermatol. 1980 May;74(5):307–308. doi: 10.1111/1523-1747.ep12543526. [DOI] [PubMed] [Google Scholar]
  2. Berman B., France D. S., Martinelli G. P., Hass A. Modulation of expression of epidermal Langerhans cell properties following in situ exposure to glucocorticosteroids. J Invest Dermatol. 1983 Mar;80(3):168–171. doi: 10.1111/1523-1747.ep12533397. [DOI] [PubMed] [Google Scholar]
  3. Haim S., Gilhar A. Clinical and laboratory criteria for the diagnosis of Behçet's disease. Br J Dermatol. 1980 Mar;102(3):361–363. doi: 10.1111/j.1365-2133.1980.tb08156.x. [DOI] [PubMed] [Google Scholar]
  4. Haim S., Mekori T., Sobel J. D., Robinson E. Aspects of lymphocyte function in Behçet's disease. Dermatologica. 1976;153(1):34–37. doi: 10.1159/000251104. [DOI] [PubMed] [Google Scholar]
  5. LUFT J. H. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol. 1961 Feb;9:409–414. doi: 10.1083/jcb.9.2.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lehner T. Immunologic aspects of recurrent oral ulcers. Oral Surg Oral Med Oral Pathol. 1972 Jan;33(1):80–85. doi: 10.1016/0030-4220(72)90211-3. [DOI] [PubMed] [Google Scholar]
  7. MacKie R. M. A monoclonal antibody technique to demonstrate an increase in Langerhans cells in cutaneous lesions of mycosis fungoides. Clin Exp Dermatol. 1982 Jan;7(1):43–47. doi: 10.1111/j.1365-2230.1982.tb02383.x. [DOI] [PubMed] [Google Scholar]
  8. Mishima Y., Kawasaki H., Pinkus H. Dendritic cell dynamics in progressive depigmentations. Distinctive cytokinetics of -dendritic cells revealed by electron microscopy. Arch Dermatol Forsch. 1972;243(2):67–87. [PubMed] [Google Scholar]
  9. O'duffy J. D. Summary of International Symposium on Behçet's Disease. Istanbul, September 29-30, 1977. J Rheumatol. 1978 Summer;5(2):229–233. [PubMed] [Google Scholar]
  10. Rowden G., Lewis M. G. Langerhans cells: involvement in the pathogenesis of mycosis fungoides. Br J Dermatol. 1976 Dec;95(6):665–672. doi: 10.1111/j.1365-2133.1976.tb07044.x. [DOI] [PubMed] [Google Scholar]
  11. Rowden G., Lewis M. G., Sullivan A. K. Ia antigen expression on human epidermal Langerhans cells. Nature. 1977 Jul 21;268(5617):247–248. doi: 10.1038/268247a0. [DOI] [PubMed] [Google Scholar]
  12. Saito T., Honma T., Saigo K. Epidermal Langerhans' cells after the prick test for Behçet's disease. Dermatologica. 1980;161(3):152–156. doi: 10.1159/000250351. [DOI] [PubMed] [Google Scholar]
  13. Shelley W. B., Juhlin L. Langerhans cells form a reticuloepithelial trap for external contact antigens. Nature. 1976 May 6;261(5555):46–47. doi: 10.1038/261046a0. [DOI] [PubMed] [Google Scholar]
  14. Shelley W. B., Juhlin L. The Langerhans cell: its origin, nature, and function. Acta Derm Venereol Suppl (Stockh) 1978;58(79):7–22. [PubMed] [Google Scholar]
  15. Stingl G., Katz S. I., Clement L., Green I., Shevach E. M. Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol. 1978 Nov;121(5):2005–2013. [PubMed] [Google Scholar]
  16. Stingl G., Katz S. I., Shevach E. M., Rosenthal A. S., Green I. Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. J Invest Dermatol. 1978 Jul;71(1):59–64. doi: 10.1111/1523-1747.ep12544055. [DOI] [PubMed] [Google Scholar]
  17. Stingl G., Wolff-Schreiner E. C., Pichler W. J., Gschnait F., Knapp W., Wolff K. Epidermal Langerhans cells bear Fc and C3 receptors. Nature. 1977 Jul 21;268(5617):245–246. doi: 10.1038/268245a0. [DOI] [PubMed] [Google Scholar]
  18. Streilein J. W., Bergstresser P. R. Langerhans cell function dictates induction of contact hypersensitivity or unresponsiveness to DNFB in Syrian hamsters. J Invest Dermatol. 1981 Sep;77(3):272–277. doi: 10.1111/1523-1747.ep12482453. [DOI] [PubMed] [Google Scholar]
  19. Tarnowski W. M., Hashimoto K. Langerhans' cell granules in histiocytosis X. The epidermal Langerhans' cell as a macrophage. Arch Dermatol. 1967 Sep;96(3):298–304. [PubMed] [Google Scholar]
  20. Wolff K. The fine structure of the Langerhans cell granule. J Cell Biol. 1967 Nov;35(2):468–473. doi: 10.1083/jcb.35.2.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wolff K. The langerhans cell. Curr Probl Dermatol. 1972;4:79–145. [PubMed] [Google Scholar]
  22. Zelickson A. S. Granule formation in the Langerhans cell. J Invest Dermatol. 1966 Nov;47(5):498–502. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES